PROT# CA-ALT-801-02-09: Phase Ib/II Study of ALT-801 with Cisplatin in Patients with Metastatic Melanoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/20/10 → 2/4/13

Funding

  • Altor BioScience Corporation (CA-ALT-801-02-09//2R44CA097550-05A1)
  • National Cancer Institute (CA-ALT-801-02-09//2R44CA097550-05A1)
View all
View less